Therapy for Caregiver Depression
(CARES Trial)
Trial Summary
What is the purpose of this trial?
This trial tests a program called SAMM, which helps caregivers of dementia patients plan and track morning activities. The goal is to reduce depression by getting them more active in the morning. Increased morning activity is expected to lower negative thinking and improve brain function related to mood.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it mentions that participants should have no or stable medication for depression. This suggests that if you are on depression medication, it should be stable and not recently changed.
What data supports the effectiveness of the treatment for caregiver depression?
Research shows that chronotherapy, which includes adjusting sleep schedules and exposure to light, can help reduce depressive symptoms. Studies have found that these methods are effective in treating depression, especially when combined with other therapies, and can improve recovery and reduce hospital stays.12345
Is the therapy for caregiver depression safe for humans?
How does this treatment for caregiver depression differ from other treatments?
This treatment is unique because it involves chronotherapy, which uses strategies like controlling light exposure and adjusting sleep patterns to influence the body's biological clock. Unlike traditional treatments that may focus on medication, this approach targets the timing of environmental cues to improve mood and reduce depressive symptoms.12389
Research Team
Stephen F Smagula, PhD
Principal Investigator
University of Pittsburgh
Eligibility Criteria
This study is for individuals aged 60 or older who are unpaid caregivers to someone with dementia, feeling stressed, and have trouble getting going in the morning. They shouldn't be currently receiving cognitive therapy, have a substance use disorder, probable dementia themselves, or any condition that prevents MRI scans.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in the SAMM protocol or a supportive control condition to increase morning activity engagement over a 6-week period
Follow-up
Participants are monitored for changes in depression, anxiety, and other health measures
Treatment Details
Interventions
- Activity Strategy-based Session with Therapist (Behavioural Intervention)
- Advance sleep-wake time (Behavioural Intervention)
- Attention-based Session with Therapist (Behavioural Intervention)
- Morning Action Plan Execution (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator